Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel.
Department of Biochemistry and Molecular Genetics, Israel Institute for Biological Research, Ness-Ziona, Israel.
Vaccine. 2017 Dec 15;35(50):7001-7009. doi: 10.1016/j.vaccine.2017.10.053. Epub 2017 Nov 6.
Francisella tularensis is the intracellular bacterial pathogen causing the respiratory life-threatening disease tularemia. Development of tularemia vaccines has been hampered by an incomplete understanding of the correlates of immunity. Moreover, the importance of lung cellular immunity in vaccine-mediated protection against tularemia is a controversial matter. Live attenuated vaccine strains of F. tularensis such as LVS (Live Vaccine Strain), elicit an immune response protecting mice against subsequent challenge with the virulent SchuS4 strain, yet the protective immunity against pulmonary challenge is limited in its efficacy and longevity. We established a murine intra-nasal immunization model which distinguishes between animals fully protected, challenged at 4 weeks post double-vaccination (200 inhalation Lethal Dose 50%, LD, of SchuS4), and those which do not survive the lethal SchuS4 infection, challenged at 8 weeks post double vaccination. Early in the recall immune response in the lung (before day 3), disease progression and bacterial dissemination differed considerably between protected and non-protected immunized mice. Pre-challenge analysis, revealed that protected mice, exhibited significantly higher numbers of lung Ft-specific memory T cells compared to non-protected mice. Quantitative PCR analysis established that a higher magnitude, lung T cells response was activated in the lungs of the protected mice already at 24 h post-challenge. The data imply that an early memory response within the lung is strongly associated with protection against the lethal SchuS4 bacteria presumably by restricting the dissemination of the bacteria to internal organs. Thus, future prophylactic strategies to countermeasure F. tularensis infection may require modulation of the immune response within the lung.
土拉弗朗西斯菌是一种细胞内细菌病原体,可引起呼吸道致命疾病——兔热病。由于对免疫相关性的认识不完整,兔热病疫苗的开发一直受到阻碍。此外,肺部细胞免疫在疫苗介导的兔热病保护中的重要性是一个有争议的问题。活减毒疫苗株如 LVS(活疫苗株)可引发免疫反应,保护小鼠免受随后强毒 SchuS4 株的攻击,但对肺部攻击的保护免疫力在其效力和持久性方面存在局限性。我们建立了一种小鼠鼻腔免疫模型,该模型可区分完全受保护的动物(在双疫苗接种后 4 周(200 吸入致死剂量 50%,LD,SchuS4)进行挑战)和未在致命 SchuS4 感染后存活的动物(在双疫苗接种后 8 周进行挑战)。在肺部回忆免疫反应早期(第 3 天之前),受保护和未受保护的免疫小鼠之间的疾病进展和细菌传播有很大差异。在挑战前分析中,与未受保护的免疫小鼠相比,受保护的小鼠肺部 Ft 特异性记忆 T 细胞数量明显更高。定量 PCR 分析表明,在保护小鼠的肺部,已经在挑战后 24 小时激活了更高幅度的肺部 T 细胞反应。这些数据表明,肺部的早期记忆反应与免受致命 SchuS4 细菌的保护密切相关,可能通过将细菌的传播限制在内部器官来实现。因此,未来针对土拉弗朗西斯菌感染的预防策略可能需要调节肺部的免疫反应。